TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls. Rachel Novotny, Ph.D. Honolulu, HI 96822

Similar documents
CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

Award Number: W81XWH

Fort Detrick, Maryland

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

Approved for public release; distribution unlimited

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Detection of Prostate Cancer Progression by Serum DNA Integrity

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

TITLE: Exploring Early Detection Methods: Using the Intraductal Approach to Predict Breast Cancer

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer

Approved for public release; distribution unlimited

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

Award Number: W81XWH

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029

TITLE: Polychlorinated Biphenyls, Organochlorines & PD Risk: A Case Control Study in Alaska

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

TITLE: "Impact of Obesity on Tamoxifen Chemoprevention in a Model of Ductal Carcinoma in Situ"

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

Award Number: MIPR 3GD3DN3081. TITLE: Outcomes of Telehealth Group Psychosocial Interventions for Breast Cancer Patients and Their Partners

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

CONTRACTING ORGANIZATION: The Trustees of Columbia University in City of New York New York, NY

Award Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

TITLE: Genetic and epigenetic biomarkers for recurrent prostate cancer after radiotherapy

CONTRACTING ORGANIZATION: Joan & Sanford I. Weill Medical College of Cornell University New York, NY 10065

Expression and Promoter Methylation of P16INK4A During Estrogen-Induced Mammary Carcinogenesis in the ACI Rat. Omaha, NE

Award Number: W81XWH TITLE: A Novel Membrane-Permeable, Breast-Targeting, Pro-Apoptotic Peptide for Treatment of Breast Cancer

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Mission Connect Mild TBI Translational Research Consortium. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

CONTRACTING ORGANIZATION: University of Texas M.D. Anderson Cancer Center Houston, TX 77030

// Award Number: DAMD TITLE: Markers of Breast Cancer Risk in Women with Benign Breast Disease PRINCIPAL INVESTIGATOR:

Promote Adjustment during Reintegration following Deployment

Transcription:

AD AWARD NUMBER: W81XWH-07-1-0489 TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls PRINCIPAL INVESTIGATOR: Gertraud Maskarinec, M.D., Ph.D. Rachel Novotny, Ph.D. CONTRACTING ORGANIZATION: University of Hawaii at Manoa Honolulu, HI 96822 REPORT DATE: July 2009 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for Public Release; Distribution Unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE 2. REPORT TYPE 3. DATES COVERED 1 July 2009 Annual 18 Jun 2008 17 Jun 2009 4. TITLE AND SUBTITLE 5a. CONTRACT NUMBER Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls 5b. GRANT NUMBER W81XWH-07-1-0489 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d. PROJECT NUMBER Gertraud Maskarinec, M.D., Ph.D. Rachel Novotny, Ph.D. E-Mail: Morimoto@crch.hawaii.edu 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER University of Hawaii at Manoa Honolulu, HI, 96822 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for Public Release; Distribution Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT Increasing evidence suggests that breast cancer risk is determined early in life. Mammographic density has been used as a biomarker for breast cancer risk because of its strong association with breast cancer. However, use of this screening method is contraindicated in young women and girls because the risk of X-ray based mammograms outweighs potential benefits in that age group. In contrast, Dual Energy X-ray Absorptiometry (DXA) has extremely low radiation and is commonly available. The specific aims of this project among adult women and adolescent girls, who will be recruited as mothers and daughters, will be to 1. Correlate breast density measured by DXA with mammographic density among adult women; 2. Compare the association of known breast cancer risk factors with breast density from DXA scans to their association with mammographic density; 3. Assess DXA breast density by Tanner stage of breast maturation among adolescent girls; 4. Relate DXA breast density to other observable measures of pubertal maturation, e.g., height and menarche; and 5. Examine the relation between breast density measured by DXA in mothers and daughters. During this year, we have recruited 19 mother-daughter pairs plus one additional daughter and obtained DXA scan images from all participants. We project to recruit the remaining 80% (81 motherdaughter pairs) and complete data collection by the end of next year. Upon completion of the study, our multiethnic sample will generate a pilot data on the DXA scan as a method to evaluate breast cancer risks in women and young girls from various ethnic groups. 15. SUBJECT TERMS Breast cancer, Dual Energy X-ray Absorptiometry, mammographic, breast cancer risk, adolescents 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U 18. NUMBER OF PAGES c. THIS PAGE U UU 8 19a. NAME OF RESPONSIBLE PERSON USAMRMC 19b. TELEPHONE NUMBER (include area code) Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std. Z39.18

Table of Contents (4) Introduction.....4 (5) Body..4-5 (6) Key Research Accomplishments....None (7) Reportable Outcomes..None (8) Conclusions...6 (9) References.None (10) Appendices None (11) Supporting Data...6-8

(4) Introduction Increasing evidence suggests that breast cancer risk is determined early in life. However, use of mammography as a screening method is contraindicated in young women and girls because the risk of X-ray exposure outweighs potential benefits in that age group. In contrast, Dual Energy X-ray Absorptiometry (DXA) has extremely low radiation and is commonly available. The rationale of this project is that predictors of breast cancer risk may be observed during pubertal development in girls. Our hypotheses are as follows: 1. DXA imaging can provide a valid assessment of breast density in adult women and in young girls. 2. DXA assessed breast density is associated with indicators of pubertal maturation and with known breast cancer risk factors. 3. Due to its strong genetic component, breast density obtained from the DXA scans is correlated between mothers and adolescent daughters. The specific aims of this project among adult women and adolescent girls, who will be recruited as mothers and daughters, are to: 1. Correlate breast density measured by DXA with mammographic density among adult women. 2. Compare the association of known breast cancer risk factors with breast density from DXA scans to their association with mammographic density. 3. Assess DXA breast density by Tanner stage of breast maturation among adolescent girls. 4. Relate DXA breast density to other observable measures of pubertal maturation (e.g., height and menarche). 5. Examine the relation between breast density measured by DXA in mothers and daughters. We aim to recruit a total of 100 adult women with daughters between 8-16 years of age. Based on the ethnic distribution of Hawaii s population, we expect that approximately half of the study subjects will be of Asian (primarily Japanese, Chinese, and Filipino) and Pacific Islander descent. (5) Body During this year, we have accomplished the following tasks as outlined in the approved Statement of Work. Task 1. Study plan and procedures. Task 1.a. Study manual. Last year through earlier this year, we faced a lower-than-expected participant enrollment rate. To improve our recruitment efforts, we made modifications to the participant eligibility criteria that include: 1) expanding BIRADS to include categories 1-3; 2) expanding mothers age group to 30 years and older; and 3) dropping oral contraceptive use. These modifications and related revisions to the study protocol and study forms were approved by all IRBs. Moreover, we developed a study flyer and follow-up letters to send to Kaiser members who did not reply to our initial recruitment letters. Subsequently, we received Kaiser and UH CHS approvals; however, we did not seek DOD approval, as participant enrollment improved during the 2 nd quarter. We reached our goal of recruiting 100 mother-daughter pairs in the 3 rd quarter. Task 1.b. Subcontracts. We continued collaborative efforts with the University of California at San Francisco (UCSF) and with Kaiser Permanente Hawaii under subcontracts established during the first year. Task 1.c. DXA procedures. DXA procedure was established and outlined in the DXA Operator s Manual during the first year. No modifications were made this year. Task 1.d. Plan recruitment strategy with Kaiser. We made modifications to participant eligibility criteria as previously described in Task 1.a. Revised criteria are described in the approved Study Protocol. Task 1.e. Train DXA technician. Training of a licensed x-ray technician at the Clinical Research Center, University of Hawaii was completed during the first year. No additional training was required this year. 4

Task 1.f. Establish study database. A password-protected, study database was created during the first year to be accessed by authorized study personnel for participant data entry and analysis. This database will be merged with both mammographic density data and DXA scan data for further analysis. Task 1.g. Purchasing study supplies. Additional twenty gift cards were purchased this year. A total of 220 cards have been purchased. Task 2. Subject recruitment. This year, we mailed 3,491 invitation letters through Kaiser to eligible mothers and daughters, making it a total of 3,915 letters mailed through Years 1 and 2. Among those who responded, we enrolled 102 mothers and 112 daughters and completed our recruitment in the second half of this year. Task 3. Conduct study visits. Study visits were conducted by trained research staff members at the Clinical Research Center including a licensed x-ray technician. These staff members were trained in explaining the study procedures, performing final eligibility check, obtaining informed consent/assent, administering the study questionnaire, and collecting anthropometric measurements. In addition, the x-ray technician had previously been trained in conducting Tanner-stage assessments of pubertal development (breast and pubic hair), and has performed the assessments of all 112 girls participated in our study. Task 4. Perform DXA scans. A licensed x-ray technician who received training for this study performed scans of the whole body and breasts on a Lunar Prodigy DXA Bone Densitometer (DF+12484). DXA scans were obtained from all participants. Scanned images were saved on a password-protected USB memory drive each day as directed by the DXA Operator s Manual. At the end of each month, these images were burned to a CD, protected by password, and mailed to University of California at San Francisco, Breast Bone Density Group (UCSF BBDG) via FedEx by the project coordinator. Task 5. Perform Breast Density Analysis. After all mothers and daughters have completed study visits, we obtained screening mammogram films from Kaiser and non-kaiser clinics. We have obtained 94 mothers mammogram films so far, and we are currently in the process of obtaining the remaining 8 mothers films. These mammogram films were scanned on a Kodak LS80 digitalizer into a password-protected computer. All personal identifiers were removed from the scanned images, which were then saved with study participant ID numbers. After delineating total and dense breast areas, the percentage density was calculated as the ratio of the dense area to the total area. All mammograms for one woman were assessed during the same session. DXA scan images of all participants have been sent to UCSF BBDG and are currently being analyzed for density measures. We are excepting to receive the results from UCSF shortly. Task 6. Data Management and Analysis. All participants data have been entered into a password-protected, study database including demographic data, health and menstrual/reproductive information, anthropometric measures, and Tanner stages for girls. Using SAS Version 9.1, we calculated the summary statistics to describe our participant-recruitment (Figure 1), as well as the demographics of the final study population (Table 1), which consisted of 102 mothers and 112 daughters. Mean age of the mothers was 47.0±4.4 years, and that of the daughters was 13.4±1.7 years. Their self-reported ethnicities reflected the diverse population of Hawaii (Table 1). Tanner stage assessments of the breast and pubic hair indicated a successful recruitment of girls from all 5 levels of pubertal development (Table 2). During these analyses, we checked for data entry errors in the database. We will conduct further statistical analysis when density measures from mammography and DXA scans become available for all participants. 5

(6) Key Research Accomplishments None to date. (7) Reportable Outcomes None to date. (8) Conclusions This year, we completed participant recruitment and DXA scans. We are currently working on finishing mammographic density analysis while waiting to receive DXA image analysis results from UCSF. When both of these become available, we will further proceed with statistical data analysis including correlation coefficients, general linear models, and mixed models. Such analysis will generate pilot data on the DXA scan in mother-daughter and provide more information about the heritable aspects of breast density from an ethnically-diverse population. Moreover, the current study will develop a technique that will provide a unique tool to screen for breast cancer risk in early life and aid in developing prevention strategies. (9) References No articles cited. (10) Appences None. (11) Supporting Data Figure 1: Recruitment and Study Population (Page 7) Table 1: Participants demographic Information (Page 8) Table 2: Daughters Tanner stage distribution (Page 8) 6

Figure 1. Recruitment and Study Population 3915 Invitation letters sent 304 Mothers with daughters expressed interest in study 166 Ineligible mothers with daughters due to: 138 Eligible mothers with eligible daughters scheduled study visits 50 No mammograms 42 Age 18 Biological mother/daughter not available 18 History of breast cancer/surgery or abnormal mammogram/biopsy 12 Breast implants 10 Not interested/unable to contact 9 Daughter with no breast development 4 Off island 3 Health problems 102 mothers with daughters completed study: o o o 90 mothers with one daughter 11 mothers with 2 daughters 1 mother with no daughter 7

Table 1. Participants demographic Information Ethnic category Japanese W hite Hawaiian & other pacific Other Asian Other To tal P value*** N 22 32 18 25** 5 102 -- Age (years) 49.0±4.6 47.4± 4.3 46.0±4.5 45.8± 4.0 45.0±2.7 47.0± 4.4.08 BMI (kg/m 2 ) 26.0± 5.6 26.6±5.8 26.9±5.6 30.2± 5.7 34.2±5.8 27.5± 5.9.01 Mothers Age at menarche (years) Age at first child birth (years) Number of children 11.9±1.1 12.9± 1.6 11.8±1.3 13.3± 2.0 13.2±1.9 12.5± 1.6 <.01 30.5±6.0 30.0± 5.4 29.8±5.7 25.7± 5.8 27.1±4.2 29.1± 5.8.05 2.4±1.0 2.5±1.0 2.2±0.6 3.0±1.4 2.4±1.1 2.5±1.0.13 Menstruation Yes/No (N) 10/12 13/18 8/10 6/19 1/4 38/63.59 Hormone (estrogen) 32 16 22 21 0 21.52 use (%) Overweight/ obese (%) 36/14 28/25 33/44 36/20 20/80 32/28 -- N 25 35 29 16 7 112 -- Age (years) 13.6±1.6 13.5± 1.6 13.0±1.7 12.9± 2.1 14.3±1.3 13.4± 1.7.23 Daughters Weight (kg) 50.6±11.4 52.4±13.6 58.2± 17.3 51.1±11.5 64.2± 15.0 54.1± 14.3.07 Height (cm) 154.0±6.3 158.6±9.5 159.9±8.7 154.2 ±7.7 160.3±4.3 157.4 ±8.4.03 Reached 18 23 21 12 5 79.96 menarche (N) Including 10 Chinese, 13 Filipino, 1 Korean and 1 Other Asian Including 1 Black, 2 Hispanic, 1 Native American and 1 Other. N = 100. Based on self-reported hormone (estrogen) use. Excluded 2 mothers who reported IUD and Lupron. Menstruation status was determined based on the last menstrual period within the past 60 days. Excluding 1 mother with missing last period date * Overweight: BMI 25; Obese: BMI 30. ** Including 1 mother (Other Asian) whose daughter refused to participate. *** P value among the 5 ethnic categories. Table 2: Daughters Tanner stage distribution Tanner Tanner N Stage Stage N Breast 1-2 17 0-2 20 3 38 Pubic Hair 3 26 4 13 4 52 5 44 5 12 Total 112 Total 110* *Two daughters refused to complete Tanner pubic-hair assessment. 8